Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gasperini

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patientsA Poggi, M R Zocchi, P Costa, et al.
Cell Death & Disease|June 13, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Cell Death & Disease|May 8, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
AJNR. American Journal of Neuroradiology|April 1, 1997
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesionsS Bastianello, A Bozzao, A Paolillo, et al.
Journal of Neurology|March 1, 1997
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeE Millefiorini, C Gasperini, C Pozzilli, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 1, 1996
Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parametersC Gasperini, M A Horsfield, J W Thorpe, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional studyC Solaro, G Brichetto, M P Amato, et al.
World Neurosurgery|October 10, 2025
Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive CasesA Fratini, C Noya, S Santi, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patientsA Poggi, M R Zocchi, P Costa, et al.
Cell Death & Disease|June 13, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Cell Death & Disease|May 8, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
AJNR. American Journal of Neuroradiology|April 1, 1997
Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesionsS Bastianello, A Bozzao, A Paolillo, et al.
Journal of Neurology|March 1, 1997
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcomeE Millefiorini, C Gasperini, C Pozzilli, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 1, 1996
Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parametersC Gasperini, M A Horsfield, J W Thorpe, et al.
Brain : a Journal of Neurology|November 3, 1998
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trialsM Filippi, M Rovaris, R Capra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2011
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosisE Sbardella, V Tomassini, M L Stromillo, et al.
Neurology|September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional studyC Solaro, G Brichetto, M P Amato, et al.
World Neurosurgery|October 10, 2025
Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive CasesA Fratini, C Noya, S Santi, et al.
Pageof 10